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High-coverage whole-genome sequencing data of a single ethnicity can provide a useful catalogue 
of population-specific genetic variations, and provides a critical resource that can be used to more 
accurately identify pathogenic genetic variants. We report a comprehensive analysis of the Korean 
population, and present the Korean National Standard Reference Variome (KoVariome). As a part of the 
Korean Personal Genome Project (KPGP), we constructed the KoVariome database using 5.5 terabases 
of whole genome sequence data from 50 healthy Korean individuals in order to characterize the benign 
ethnicity-relevant genetic variation present in the Korean population. In total, KoVariome includes 
12.7M single-nucleotide variants (SNVs), 1.7M short insertions and deletions (indels), 4K structural 
variations (SVs), and 3.6K copy number variations (CNVs). Among them, 2.4M (19%) SNVs and 0.4M 
(24%) indels were identified as novel. We also discovered selective enrichment of 3.8M SNVs and 0.5M 
indels in Korean individuals, which were used to filter out 1,271 coding-SNVs not originally removed 
from the 1,000 Genomes Project when prioritizing disease-causing variants. KoVariome health records 
were used to identify novel disease-causing variants in the Korean population, demonstrating the value 
of high-quality ethnic variation databases for the accurate interpretation of individual genomes and the 
precise characterization of genetic variations.
The human reference genome1 was a milestone of scientific achievement and provides the foundation for bio-
medical research and personalized healthcare2. The completion of the human genome marked the beginning of 
our concerted efforts to understand and catalogue genetic variation across human populations. The International 
HapMap project resolved human haplotypes into more than one million common single nucleotide poly-
morphisms (SNPs) in an effort to catalogue genetic variations associated with diseases3. Subsequently, other 
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large-scale genomic studies have identified 360M copy number variations (CNVs)4 and 6.4M small insertions and 
deletions (indels)5. These efforts laid the groundwork for approximately 1,800 genome-wide association (GWA) 
studies that investigated the genetic basis of complex diseases such as diabetes, cancer, and heart disease6. While 
these GWA studies have identified a wide range of disease-associated alleles that can be used as diagnostic tools7, 
the majority of the findings are associated with low disease risks and have led to a renewed focus on the detection 
of rare variants that are more predictive of disease8.
To identify pathogenic rare variants, disease cohorts are compared to population-scale variomes generated 
from healthy controls to remove common and low frequency variants in diverse human ethnic groups9,10. As a 
result, numerous population genomic studies have been performed to characterize ethnicity-relevant variations. 
One of the largest of such efforts, the 1,000 Genomes Project (1000GP), reported a total of 88M genetic variants, 
including SNPs, indels, and structural variations (SVs) from 2,504 healthy individuals11, and resolved population 
stratification by sampling 26 populations across five continents; Africa (AFR), East Asia (EAS), Europe (EUR), 
South Asia (SAS), and Americas (AMR). More recently, the Exome Aggregation Consortium (ExAC) released 
ten million human genetic variants from 60,706 individuals with a resolution of one exonic variant for every 
eight base-pairs12. Analysis of high coverage sequencing data (more than 30x) from 10,000 individuals showed 
that each newly analyzed genome added roughly 0.7MB of new sequences to the human reference genome and 
contributed an average of 8,579 new SNVs to the existing human variation data set13. Large-scale variome stud-
ies, such as those previous discussed, have significantly increased our understanding of variation in the human 
population, however, the population composition is still broadly biased towards Europeans (54.97% in ExAC12 
and 78.55% in Telenti et al.13). Consequently, many groups have initiated small variome studies of more targeted 
populations, i.e. the Malays14, Dutch (GoNL)15, Danish16, Japanese (1KGPN)17, Finland, and United Kingdom18. 
The large number of population-specific variations discovered in these studies highlights the importance of single 
population variomes in creating comprehensive databases of population heterogeneity and stratification.
SVs are also an important type of genomic variation in the human population that contribute significantly 
to genomic diversity19. SVs include large insertions (INSs), deletions (DELs), inversions (INVs), translocations, 
and CNVs20. Unlike SNVs and small indels, however, the identification of SVs remains challenging. It is largely 
because of genome complexities and the limitations of short-read sequencing technologies21. Current efforts to 
resolve SVs reported several population-scale SVs16,19 and CNVs17,22 from whole genome sequencing (WGS) 
data, and these analyses characterized population-specific traits such as amylase gene duplication in high-starch 
diet populations17,23 and revealed associations for specific diseases such as hemophilia A24, hunter syndrome25, 
autism26, schizophrenia27, and Crohn’s disease28 with SVs. Nevertheless, SVs identified in healthy individuals 
also contain a substantial number of individual- and population-specific SVs with no disease association. Taken 
together, these results have demonstrated the importance of constructing population-specific SV and CNV pro-
files for the characterization of disease association and identifying diagnostic markers for precision medicine.
The Korean population is regarded as a homogeneous ethnic group in East Asia29, from which a relatively small 
set of samples can produce a high-coverage population variome. Since the first Korean whole genome sequences were 
reported in 200930, further variome studies in the Korean population have been conducted in the last decade using 
low-cost next generation sequencing (NGS) technologies31–36. Two exonic variomes of more than 1,000 Koreans were 
reported, though sampling was focused on disease cohorts containing patients with type II diabetes mellitus, hemo-
philia, cancer, and other rare diseases35,36. Consequently, these studies are not suitable for parsing benign, demographic 
variants from disease variants. As the Korean center of the Personal Genome Project (PGP)17, the Korean Personal 
Genome Project (KPGP or PGP-Korea) was initiated in 2006 by the Korean Bioinformation Center (KOBIC) to char-
acterize ethnicity-relevant variation in Korea by providing a comprehensive genomic, phenomic, and enviromic dataset 
accessible to researchers across the world. Since KPGP published the first Korean genome with NGS data in 200930, 
the number of complete genomes has increased to 60 genomes as of 2016. This population was used to construct the 
first consensus Korean Reference genome standard (KOREF_C)37, which was registered as a standard reference for the 
ethnic Korean genome sequences by evaluating its traceability, uncertainty, and consistency in the beginning of 2017.
To characterize the genomic variations across the Korean population, we selected and analyzed WGS data 
from 50 unrelated, healthy Korean individuals in the KPGP cohorts with associated clinical diagnoses and family 
histories related to major diseases. In this report, we describe the general features of KoVariome and character-
ize all four types of genomic variations, which include 12.7M SNVs, 1.7M indels, 4K SVs, and 3.6K CNVs. This 
comprehensive database of genomic variations and corresponding metadata will be continuously updated and 
become a valuable resource to the genomic community as researchers search for the genetic basis of disease.
Results and Discussion
Construction of the Korean standard Variome: KoVariome. Since 2010, the Korean variome data center 
(KOVAC), as a part of the KPGP, has been recruiting volunteers to generate WGS and whole exome sequencing 
(WES) data. The current KoVariome (version 20160815) has been constructed based on WGS data from 50 unre-
lated Korean individuals who responded to questionnaires detailing body characteristics, habits, allergies, fam-
ily histories, and physical conditions related to 19 disease classes (Supplementary Table S1). A total of 5.5 TB of 
high-quality paired-end WGS data were generated, containing an average of 31× coverage per individual (Table 1 
and Supplementary Table S2). WGS data from each individual covered 95% of the human reference genome (hg19) 
on average. From these data, we identified approximately 3.8M SNVs (ranged 3.7–3.9M) and 0.5M indels (0.4–
0.7M) per Korean individual (Table 1 and Supplementary Fig. S1A). The hetero-to-homozygosity ratio of the auto-
somal SNVs was 1.49, which is consistent with previously reported data38. The length distributions of the indel loci 
were symmetric, with the majority of indel sizes shorter than six bases (94.8% for insertions, 97.8% for deletions) 
(Supplementary Fig. S1B). We identified approximately 20,097 (0.53%) SNVs and 258 (0.05%) indels in the coding 
regions including 10,394 (0.22%) non-synonymous changes per individual (Table 1).
www.nature.com/scientificreports/
3Scientific REPORtS |  (2018) 8:5677  | DOI:10.1038/s41598-018-23837-x
Novel KoVariome SNVs were counted by adding individual samples one by one (Fig. 1A), and the number 
of novel SNVs decreased logarithmically and became depleted after the 9th donor. In total, we observed 59K 
novel SNVs, including 1.2K (2.03%) coding-SNVs, per individual. To assess the relatedness of the KoVariome 
individuals, we compared the pairwise genetic distance of KoVariome with those of family data (Fig. 1B). WGS 
data from thirty families were downloaded from the KPGP database, which included two monozygotic twins, 14 
parent-children pairs, seven siblings, five grandparents-grandchildren, six uncles-nephews, and three cousins. We 
analyzed familial SNVs using the same method as in KoVariome and also compared genetic distances between 
the two groups (see Methods). The genetic distance among KoVariome individuals was higher (pi = 8.8e-4) than 
those found in the familial data, such as monozygotic twins (4.8e-4), siblings (6.7e-4), parent-child (6.8e-4), 
uncle-nephew (7.7e-4), grandparents-grandchild (7.8e-4), and cousins (8.2e-4). This verifies that no genetic bias 
was present in the sample collection stage and current KoVariome. In accordance with previous reports, the 
multidimensional scaling (MDS) of variants among Korean, Chinese, and Japanese individuals showed a clear 
separation of the three populations (Fig. S2) despite the geographical and historical associations between these 
groups35,37. These analyses reinforce the need for distinct KOREF and KoVariome reference resources to parse 
disease variants from demographic variants in this population.
Accuracy test of SNVs and indels in KoVariome. We evaluated the accuracy of KoVariome SNV and 
indel predictions by comparing genotype results from the AxiomTM Genome-ASI 1 Array with WGS data from 35 
individuals. A total of 503,694 SNV positions were compared, from which we obtained an average of 0.9993 pre-
cision (ranged: 0.9984–0.9996) and 0.9980 recall (ranged: 0.9817–0.9994) (Supplementary Table S3). In addition, 
there was a 99.65% (ranged: 98.62–99.87%) concordance of the SNVs called by the WGS and Axiom array calls. 
Compared to similar variome studies, this genotype accuracy was slightly lower than the high-depth trio data in 
the Danish population study (99.8%)16 but higher than that of the Dutch population SNVs (99.4–99.5%) analyzed 
with intermediate depths39. The accuracy of the SNV calls was analyzed across the genome, and a total of 499,889 
(99.24%) SNVs showed a genotype concordance higher than 0.99, while 0.4% of SNVs showed the genotype accu-
racy less than 0.95 (Supplementary Table S4). Similar levels of genotype concordances were observed in repetitive 
regions of the genome (99.56% of SNVs with the genotype correspondence >0.95, Supplementary Table S5), 
suggesting that SNV calling accuracy is not reduced in repetitive regions of the genome.
We also compared the accuracy of indel variant calls with the 1,981 indel markers on the AxiomTM 
Genome-ASI 1 Array. A genotype comparison showed an average accuracy of 98.49% for indels, which was 
slightly lower than those observed in SNVs (Supplementary Table S3), and comparable to the false positive (FP) 
rate for indels that was reported in the Danish data16. In terms of genomic loci, 1,343 (91.11%) indels showed 
perfect genotype concordance with array data and 1,446 (98.10%) indels had an accuracy higher than 90% 
(Supplementary Fig. S3).
Genome-wide features of KoVariome. By merging the variants of 50 unrelated Korean individuals, we 
identified 12.7M SNVs and 1.7M small indels shorter than 100bp (Table 1); approximately 1.5 times the number 
of SNVs previously reported from preliminary KPGP data (8.5M)33. Both types of variants were primarily distrib-
uted in the non-coding regions (about 98%), including intergenic and intron regions (Supplementary Table S6). 
Approximately 10.3M (81.10%) SNVs and 1.3M (76.47%) indels were present in dbSNP (ver. 146); while 2.4M 
SNVs and 0.4M indels were novel (Table 1). A total of 9M (70.42%) SNVs and 0.8M (48.68%) indels were found 
Sample information for KoVariome
 No. of samples (Male/Female) 50 (31/19)
 Total NGS yield 5.5 tera bases
 Average sequenced depth 31x
 Average mapped read rates 95%
SNVs
    Total No. of SNVs 12,735,004
    No. of known variants in 1000GPa 8,967,464
    No. of known variants in dbSNPb 10,286,599
    Average No. of SNV per sample 3,813,311
    Average No. of Coding SNVsc 20,097
    Average No. of non-synonymous SNVsc 10,394
    Average No. of SNVs with high effectsc 287
Indels
    Total No. of indels 1,743,117
    No. of known variants in 1000GPa 848, 471
    No. of known variants in dbSNPb 1,307,000
    Average No. of indel per sample 503,553
    Average No. of Coding indelsc 258
    Average No. of LOF indelsc 157
Table 1. Statistics of KoVariome. Variants deposited ina 1000GP and bthe dbSNP (ver. 146). cpredicted with 
SNPEff.
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in the 1000GP variome (Supplementary Table S6); and based on allele frequencies, 4.6M (51.03%) and 4.4M 
(48.82%) of these SNVs were classified into the categories ‘1000GP common’ and ‘1000GP low frequency’, respec-
tively (Fig. 2A). Most notably, 13,584 (0.15%) KoVariome SNVs were rarely observed in the 1000GP continental 
groups with a MAF < 0.1%. A similar distribution was observed with the indels, where 64.2% and 35.8% of the 
KoVariome indels were classified into the ‘1000GP common’ (0.5M) and ‘1000GP low frequency’ (0.3M) classes, 
respectively. Only ten indels were classified into the ‘1000GP rare’ category. Almost all of the variants in the 
‘1000GP common’ category were also frequently observed in KoVariome, representing 4.5M (98.33%) SNVs 
and 0.5M (93.37%) indels in this class (Fig. 2A and Supplementary Table S6). Surprisingly, however, roughly half 
of the variants in ‘1000GP low frequency’ were classified as ‘frequent in KoVariome’. This indicates that there 
exist a significant population specific biases for common and uncommon variants. When we compared the allele 
frequencies in five the continental 1000GP groups to KoVariome. In total, we observed 3.4M (77.19%) SNVs 
and 0.2M (74.21%) indels that were statistically enriched in at least one of the continental groups or the Korean 
population (Fig. 2B), suggesting a population stratification. To further explore the population stratification, we 
identified the variants uniquely enriched in each continental group, and the enriched variants that were in com-
mon between the continental groups. In total, nearly three million (2.7M) SNVs and 156K indels were frequently 
found in the Korean population. Among them, 2.5M (95.20%) SNVs and 143K (94.47%) indels showed Korean 
specific enrichments, while the other enriched variants were shared by other continents (Fig. 2B). Among the 
five continental groups, as expected, EAS shared the largest number of enriched variants (89.5K SNPs and 5.3K 
indels) with the Korean population40.
Interpretation of the KoVariome-specific variants. Characterizing ethnicity specific variants is neces-
sary to understand the demographic differences between populations and can be used to filter out low frequency 
clustered variants in a specific group. In KoVariome, there were 3.8M SNVs and 0.9M indels not observed in the 
1000GP variome (Supplementary Table S6). A third of the 3.8M SNVs (1.1M, 29.16%), and 0.4M (40.88%) indels 
were classified as ‘frequent in KoVariome’ (Fig. 2A). Of the 15,279 non-synonymous SNVs and 480 frame-shift 
indels specific to KoVariome, 11,746 (76.88%) and 397 (82.71%) were rare in KoVariome (n < 3), respectively; 
Figure 1. Status of KPGP variomes analyzed using 50 unrelated Korean individuals. (A) Accumulation of 
novel SNV alleles. The number of novel SNV alleles were defined as newly identified nucleotides compared 
with previously constructed SNVs in KoVariome. (B) Genetic distance according to the familial relationships. 
Abbreviations: Monozygotic Twin (MT), Parent and child (PC), Brothers (Br), Grandparents vs. grand children 
(GPC), Uncle vs. Nephew (UN), and Cousins (Co).
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whereas 3,533 SNVs were frequently observed (occurring at least three times) in KoVariome but not observed in 
the 1000GP variome at all.
To identify the possible clinical relevance of these KoVariome-specific frequent variants, we compared the 
genomic loci of these SNVs against the ClinVar database and identified six likely pathogenic loci with associated 
disease information (Table 2). Two of these likely pathogenic SNVs (rs386834119 and rs1136743) were associated 
with autosomal recessive (AR) diseases, and therefore, no phenotypes were expected since all of the KoVariome 
SNVs were heterozygotes at these sites. We also observed a KoVariome allele (three males and two females) of a 
possible cancer-associated SNV (rs200564819) in RAD51D, which was previously reported to increase the risk 
of developing ovarian, breast, colorectal, lung, pancreatic, and prostate cancers41. It has been suggested that this 
allele truncates the RAD51D gene by interrupting a canonical splice site, though additional genetic data is needed 
to conclusively classify this allele as “pathogenic”42. Since there are five heterozygous rs200564819 alleles in 
KoVariome without any cancer incidence (Table 2, Table S1), these variants may not be as high-risk in the Korean 
Figure 2. Genetic features of KoVariome. (A) Two dimensional classification of KoVariome. SNVs and indels 
observed in 1000GP data were classified based on the minor allele frequencies (MAF); ’1000GP Common’: 
MAF >=5% in all five continents, ‘1000GP Low frequency’: MAF>=0.1% in any continent, and ‘1000GP 
Rare’; MAF < 0.1% in all five continents. The five continental populations included African (AFR), European 
(EUR), Native American (AMR), South Asian (SAS), and East Asian (EAS). The second group was classified by 
the number of variants in KoVariome; ‘Frequent in KoVariome’ (>=3) and ‘Rare in KoVariome’ (<3). (B) The 
Venn diagrams represent the number of variants enriched in specific continents for both SNVs (left) and indels 
(right). The enrichment was analyzed by Fisher’s exact test based on odds ratio > 3 and p-value < 0.05. The 
total numbers of enriched variants in the Korean (KOR) population are denoted in the white space of the Venn 
diagram. The numbers next to the continental population abbreviations represent the total number of enriched 
variants in that 1000GP continental group. The numbers within each ellipse denote the number of variants 
enriched both in KOR and a specific continent (left) and the number of variants enriched exclusively in the 
represented continent (right); with their relative percentages listed in parentheses below. (C) Rare variant ratios 
(RVRs) observed in each genomic region. RVRs were calculated by dividing the number rare variants by the 
number of frequent variants in KoVariome.
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population; though the database size will need to be increased to verify the effect of such population-specific dis-
ease associated markers. In addition, we observed two pathogenic missense SNVs (rs121912678 and rs20016664) 
in the KoVariome population that have been previously reported to be associated with fibrodysplasia ossificans 
progressive (FOP) and Van der Woude syndrome (VWS), respectively (Table 2). The rs121912678 SNV (chr2:g-
158630626C>G) was rarely observed in the ExAc database (MAF = 0.0002), but the C>T mutation at this posi-
tion was predicted to cause the FOP disease by constitutively activating the activin receptor type I (ACVR1)43. 
While the pathogenicity of R206P in ACVR1 due to a C>G mutation is not yet known, we suggest that it is likely 
benign because of the high MAF (0.14) of this allele in KoVariome without any FOP phenotypes, skeletal malfor-
mation, or progressive extraskeletal ossification recorded in the KPGP survey. Finally, the 400th amino acid of the 
interferon regulatory factor 6 (IRF6) gene is known to be a hot spot of VWS, orofacial clefting disorders. Two path-
ogenic variants, R400W44 and R400Q45, have been reported for VWS; however, the pathogenicity of R400P arisen 
by chr1:209961970C>G, as frequently seen in KoVariome, is not yet confirmed. A total of 14 heterozygous SNVs 
had no phenotype for VWS symptom, despite the AD inheritance pattern of this disease; and consequently, the 
R400P substitution seems to be benign. Taken together, the KoVariome-specific frequent variants demonstrate 
the importance of using population-scale health data to identify pathogenic loci in specific diseases, and for the 
accurate identification of benign variants that are not annotated because of population stratification.
Genomic distribution of rare variants. We investigated the proportion of the SNVs in four SNV classes 
(1000GP Common, 1000GP Low Frequency, 1000GP Rare, KoVariome Specific; Supplementary Fig. S4). Our 
analyses showed that a high portion of the coding SNVs were enriched in the ‘1000GP rare’ class, while the SNVs 
in the non-coding regions were similarly distributed in all other variant classes. The portion of non-synonymous 
SNVs in the ‘1000GP rare’ class was more than twice what was observed in the other classes. It is possible that 
these patterns are associated with purifying selection to rapidly remove deleterious alleles in the population46, 
though it was not possible to identify this pattern in frame-shift indels because of the small number of variants 
(981) in this class. To analyze the tendencies of purifying selection in KoVariome, we defined rare variant ratios 
(RVRs) as the number of SNVs in the ‘rare in KoVariome’ class divided by the number of SNVs in the ‘frequent in 
KoVariome’ class. We then compared RVRs across genomic regions (Fig. 2C). In both SNVs and indels, RVRs in 
the intergenic region were lowest (0.66), while similar levels of RVRs were observed in other non-coding regions 
(0.66–0.87). Under the assumption that mutations occur randomly throughout the genome, lower rates of RVR in 
non-coding regions suggest neutral selection with no or weak selection pressures in the population. Conversely, 
the highest RVR in frame-shift indels (1.45) suggests there was some purifying selection against these variants in 
the Korean population. Furthermore, about twice as many RVRs were observed in the non-synonymous (1.16) 
and splice-site (1.33) SNVs compared to intergenic regions. Although SNVs in the coding region can be deleteri-
ous to protein function, selection pressure on the non-synonymous and splice-site SNVs seem to be slightly lower 
than that of the frame-shift indels, as expected.
Interpretation of disease-causing variants among Korean individuals. Rare SNVs in an individual 
genome are more likely to be pathogenic than common variants. Because genetic variants are known to be geo-
graphically clustered, characterizing population stratification is a critical first step to identifying disease-causing 
variants47. With this concept, we examined rare SNVs in each individual after filtering out SNVs that were classi-
fied as ‘1000GP common’, ‘1000GP low frequency’, or ‘frequent’ in KoVariome. From an average of 3.8M SNVs per 
individual, 3.4M (88.70%) and 0.4M (9.39%) SNVs were filtered out using the 1000GP variome or KoVariome, 
respectively (Fig. 3A and Table 3). Overall, KoVariome allowed 1,231 (12.25%, median value) non-synonymous 
SNVs and 40 (24.01%) splice-site SNVs to be filtered out as common variants in the Korean population, which 
significantly improves the ability to pin-point disease causative variants.
After filtering, Korean donors had a median of 47,957 (1.26%) rare SNVs, most of which (98.33%) were 
located in non-coding regions. Among these, we observed an average of 219 (67.17%) non-synonymous SNVs 
and seven (0.87 %) splice-site SNVs per individual (Fig. 3B and Table 2). On average, 166 (73.45%) of these SNVs 
were present in dbSNP (ver. 146), but not in the 1000GP variome (Fig. 3C). Of the 12,445 non-synonymous rare 
Chr. Position Ref Alt rs Noa Gene
Codon 
Changes Disease
Inheritance 
Typeb Noc MAFd
17 33,445,518 A C rs200564819* RAD51D Splice-site Familial breast-ovarian cancer 4 n.a 5 0.05
1 161,599,571 T C rs2290834 FCGR3B I106V Neutrophil-specific antigens na1/na2 UNKNOWN 3 0.15
8 100,844,596 G T rs386834119 VPS13B Splice-site Cohen syndrome AR 13 0.26
2 158,630,626 C G rs121912678 ACVR1 R206P Fibrodysplasia ossificans progressive AD 14 0.14
1 209,961,970 C G rs200166664 IRF6 R400P Van der Woude syndrome AD 14 0.14
11 18,290,859 C T rs1136743 SAA1 A70V Systemic amyloidosis AR 22 0.66
Table 2. ClinVar annotation of the KoVariome frequent SNVs. AR: autosomal recessive; AD: autosomal 
dominant; Chr.: chromosome; Ref. reference allele; Alt. alternative allele. aKoVariome frequent SNVs with the 
Reference SNP cluster IDs (rs number) in ClinVar. We were only included pathogenic or likely pathogenic (*) 
SNVs. bInheritance types were searched against OMIM database with rs numbers and phenotypes represented 
in ClinVar database. ‘n.a.’ represents there are no data in the OMIM database. ‘UNKNOWN’ represents 
inheritance type for corresponding phenotype was not reported in OMIM database. cNo. of alternative allele in 
Korean population, dminor allele frequencies (MAF) in KoVariome.
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SNVs distributed in 50 Korean individuals, we identified 7,645 (61.43%) pathogenic or probably pathogenic 
SNVs predicted by at least one computational algorithm (see methods section, Table S7). In total, only 38 (0.5%) 
pathogenic rare SNVs in KoVariome were homozygotes and the remaining (99.5%) were heterozygotes. In addi-
tion, 29 (58%) of the donors had no homozygous pathogenic rare SNVs. To obtain clinical information concern-
ing these pathogenic rare-SNVs, we searched the genomic loci for these SNVs against the ClinVar database. A 
total of 127 of the rare SNVs were found in ClinVar, 53 of which showed clear clinical significance. Eight (6.39%) 
and thirteen (10.24%) were listed as benign and likely benign in ClinVar, respectively, and not fatal for a specific 
disease. Conversely, 29 (22.83%) and three (2.36%) were pathogenic and likely pathogenic, respectively (Table 4). 
These rare SNVs contribute to pathogenicity according to their inheritance patterns, and a manual investigation 
of the inheritance type using the Online Mendelian Inheritance Man (OMIM) database identified seven AD and 
17 AR SNVs for specific loci; although we failed to identify the inheritance types for eight SNV loci (Table 4). 
All 17 of the AR SNVs were heterozygous in KoVariome, so it was not possible to assign phenotypes to these 
loci. Within the donor group with pathogenic rare AD SNVs, we searched for phenotypes or familial histories 
associated with target diseases in the questionnaire. We identified a familial history for type II diabetes mellitus 
associated with rs121918673 allele in KPGP participants; however, one donor with the rs121918673 allele was 
Figure 3. Individual variants describing functional effects. (A) Classification of individual variants based 
on frequency in 1000GP and KoVariome. Gray represents the portion of individual variants classified in the 
‘1000GP common’ and ‘1000GP Low frequency’. Blue represents the portion of the individual variants classified 
in the ‘Frequent in KoVariome’. Red represents rare variants in both 1000GP and KoVariome ‘Rare in Both’. 
(B) Individual variants in the ‘Rare in Both’ were classified by gene coordinates. To more clearly represent 
the portion functionally important rare variants, 98% of the rare variants in the non-coding regions were not 
represented. (C) Number of pathogenic variants for each individual. Red and blue bars represent the number of 
pathogenic variants previously reported in dbSNP and novel, respectively.
Statistics of individual variants No. of SNVs (%)
1000GP common and 1000GP low frequency SNPs 3.4 M (88.70)
Frequent SNVs in KoVariome 0.4M (9.39)
1000GP rare and KoVariome rare SNVs 47,957 (1.26)
Statistics of individual rare SNVs
Protein-Coding 326 (40.72)
    Synonymous SNVs 107 (13.37)
    Non-synonymous SNVs 219 (27.36)
    Splice-site SNVs 7 (0.87)
RNA-Coding 80 (9.93)
Other statistics
Median No. of pathogenic rare SNVsa 137 (65.06)
Table 3. Statistics of individual SNVs. aPathogenicity of the rare SNVs were predicted by at least one program 
among SIFT, Polyphen2, PROVEAN, MetaSVM, and MetaLE.
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nondiabetic and reported no family history of this disease. Additionally, one donor was heterozygous for the 
rs121912749 allele, which has an AD association with spherocytosis, and this donor reported associated symp-
toms but no anemia (Supplementary Tables S1 and S7). However, it is clinically known that spherocytosis has 
heterogenetic symptoms ranging from asymptomatic to hemolytic anemia. These examples highlight the utility 
of population specific variation databases as an important resource for assessing the disease-relevance of genetic 
variants as a routine component of precision healthcare.
Structural variations in KoVariome. We predicted on average 6,534 individual SVs, including 450 
INVs, 354 intra-chromosomal translocations (ITXs), 478 INSs, and 5,252 DELs using BreakDancer (BD) and 
Pindel programs (Supplementary Table S8). To identify SVs with clear break points, we removed 15–32% spu-
rious SVs per individual (see Methods; Supplementary Fig. S5 and Table S8). After filtering, we obtained 40,179 
non-redundant SVs; including 4,896 INVs, 2,131 ITXs, 12,171 INSs, and 20,981 DELs. Within the Korean donor 
group, individuals contained 3,294 SVs (median), 82.36% of which were DELs (Fig. 4A). The median length of 
individual SVs was 2.3Kb for INVs, 5.8Kb for ITXs, 1.3Kb for INSs, and 342bp for DELs (Fig. 4B). A high pro-
portion of SVs were specific to an individual genome (Fig. 4C), consistent with findings from the 1KJPN17. The 
portion of individual-specific SVs was greatest for INSs (92.51%), followed by INVs (88.87%), ITXs (68.93%), and 
DELs (47.82%) (Table S8). A substantial proportion of SVs (98.5% INSs and 61% DELs) were novel and were not 
previously deposited in the Database of Genomic Variants (DGV). Overall, the non-redundant combined SVs 
ranged in size up to 10M and all classes were enriched in the 1–2Kb size range (Fig. 4D, Supplementary Fig. S6).
Individual ID rs No. Genotype
Codon 
change
Inheritance 
typea gene ClinVarTraits
KPGP-00001 rs563607795 A/G L385P n.a. SLC19A3 Thiamine metabolism dysfunction syndrome
KPGP-00001 rs199769221* G/C R116P AD PRSS1 Hereditary pancreatitis
KPGP-00032 rs387907164 T/C C32R AR KIAA1530 UV-sensitive syndrome 3
KPGP-00033 rs119490107 C/A D234Y UNKNOWN RAD54B Carcinoma of colon
KPGP-00039 rs199476197 A/C H331P AR CYP4V2 Bietti crystalline corneoretinal dystrophy
KPGP-00088 rs28940280 G/A D279N AR CLN5 Ceroid lipofuscinosis neuronal 5
KPGP-00122 rs587782989 C/T R464H AD CCDC88C Spinocerebellar ataxia 40
KPGP-00124 rs142808899 C/T G303R AR DHCR7 Smith-Lemli-Opitz syndrome
KPGP-00127 rs111033744 A/G Y100C AR GALT Galoctosemia
KPGP-00127 rs137852972 T/C N88S AD BSCL2 Silver spastic paraplegia syndrome
KPGP-00129 rs137853022 C/T R696Q AR IKBKAP Familial dysautonomia
KPGP-00129 rs386833823* G/A S238F AR SLC7A7 Lysinuric protein intolerance
KPGP-00131 rs200088377 G/A P191L n.a. IL17RD Delayed puberty
KPGP-00136 rs121908099 G/A R405Q AR CYP27A1 Cholestanol storage disease
KPGP-00136 rs750218942 C/G Splice-site AR XPA Xeroderma pigmentosum
KPGP-00136 rs727502791 G/A R158* AD MFAP5 Aortic aneurysm (familial thoracic 9)
KPGP-00136 rs545215807 G/A G109S AR ACADVL VLCAD deficiency
KPGP-00139 rs387907033 G/C G401A AR SYT14 Spinocerebellar ataxia
KPGP-00139 rs748486078 G/A S95L UNKNOWN IL17F Candidiasis
KPGP-00144 rs119480073 C/T R801 AR LPIN1 Myoglobinuria
KPGP-00144 rs104895438 G/A A612T AD NOD2 Sarcoidosis
KPGP-00205 rs121913050 G/A R153H UNKNOWN ERCC4 XFE progeroid syndrome
KPGP-00220 rs121918673 G/C S439R AD HNF1B Diabetes mellitus type 2
KPGP-00266 rs104894085 G/A Q258* AR STAR Cholesterol monooxygenase deficiency
KPGP-00227 rs121909569 A/G S148P AD, AR SERPINC1 Antithrombin III deficiency
KPGP-00228 rs121434426 G/A Q356* UNKNOWN FANCG Fanconi anemia
KPGP-00232 rs121909385 T/C L623P AR SLC12A3 Familial hypokalemia hypomagnesemia
KPGP-00233 rs672601312 G/T E127* AR ISG15 Immunodeficiency 38 with basal ganglia calcification
KPGP-00233 rs749462358 C/T E924K n.a. ASPM Not provided
KPGP-00245 rs137854500 C/T D1289N AR ABCA1 Tangier disease
KPGP-00254 rs201968272 G/A R237Q AR DDX11 Warsaw breakage syndrome
KPGP-00325 rs121912749 C/T G130R AD SLC4A1 Spherocytosis type 4
Table 4. Known pathogenic rare variants associated with disease. Abbreviations: Chr. chromosome; Ref. 
reference allele; Alt. alternative allele; AD: autosomal dominant; AR: autosomal recessive. *The clinical 
significance of SNV locus was defined as likely pathogenic in the ClinVar database. aInheritance type were 
searched against OMIM database with rs numbers and phenotypes in the ClinVar database. ‘n.a.’ represents 
there are no data in the OMIM database. ‘UNKNOWN’ represents inheritance type for corresponding 
phenotype was not reported in OMIM database.
www.nature.com/scientificreports/
9Scientific REPORtS |  (2018) 8:5677  | DOI:10.1038/s41598-018-23837-x
Finally, we analyzed the SVs to determine whether they were enriched for repetitive elements. Within the 
SVs, we cataloged repeat types and searched for Korean-specific enrichments compared to those present in other 
populations. Among the SVs, we found that 13% contained short interspersed elements (SINEs), 20% contained 
long interspersed elements (LINEs), 3.4% contained DNA transposons, and 8.6% contained long terminal repeats 
(LTRs). The majority of SINEs were observed in DELs of 200–300bp, which is consistent with de novo assembled 
SVs16 and the predicted SVs15. These results suggest that SVs are enriched for SINEs in the 1–4Kb INVs, and 
LINEs in the 4–40Kb INVs (Supplementary Fig. S6A). Additionally, simple repeats were predominantly observed 
in INSs (Figs. 4D) and 3–5Kb ITXs (Supplementary Fig. S6B).
Copy number variations in KoVariome. The high coverage WGS data used to construct KoVariome 
provides sufficient data to characterize CNVs in a single genome. The FREEC program48 predicted an average 
of 199 deletions and 336 duplications per genome (Supplementary Table S9). After filtering out spurious CNVs 
(Supplementary Fig. S7), 161.74 (81.46%) deletions and 296.72 (88.29%) duplications remained from the original 
calls. In total, we predicted 2,038 non-redundant deletions and 1,564 non-redundant duplications, and the uni-
fied CNVs were approximately 5Kb-100Kb in length (Fig. 5A). When compared to the DGV, we identified 3.6K 
known CNVs, including 1,169 (57.36%) deletions and 846 (54.09%) duplications. Repeat composition analyses of 
CNV regions revealed that deletions smaller than 5K and duplications smaller than 10K contained a 20-fold more 
simple repeats compared to their overall frequencies in the human genome. In addition, SINEs were 2-fold more 
frequent in the >600 Kb deletions. These associations differ from the repeat distributions in SVs. By examining 
Figure 4. Properties of structural variants discovered in KoVariome. (A) The boxplot represents the number 
of variants per Korean individual by variant type (n = 50). The lower and upper hinges of the boxes correspond 
to the 25th and 75th percentiles and the whiskers represent the 1.5x inter-quartile range (IQR) extending from 
the hinges. Abbreviations of the variants: inversions (INV), intra-chromosomal translocation (ITX), insertions 
(INS), and deletions (DEL). (B) Length of the variants present in the individual genome. See variant types and 
boxplot definition in A. (C) Frequency of variants in KoVariome. (D) The upper graph represents the number 
of SVs identified at specific length ranges. The KoVariome specific variants were defined by comparing SVs in 
the Database of Genomic Variants (DGV) with 70% reciprocal overlap. The lower graph represents the portion 
of repeats distributed in the variants. Repeat classes were defined by the repeat annotations provided in the 
UCSC Genome bioinformatics. Simple repeats contained both microsatellites and low complexity (e.g., AT-
rich). Abbreviations of repeats: short interspersed element (SINE), long interspersed element (LINE), and long 
terminal repeat (LTR).
www.nature.com/scientificreports/
1 0Scientific REPORtS |  (2018) 8:5677  | DOI:10.1038/s41598-018-23837-x
the genes in the unified CNVs, 869 (46.47%) deletions and 1,105 (70.65%) duplications were found to contain at 
least one gene. In addition, only two deletions and three duplications were conserved in the 50 Korean individuals 
(Table 5). Interestingly, a long 2M genomic block on chromosome 10, containing seven genes, was found to be 
duplicated an average of 4.22 times in the KPGP donors. Included among these genes is G protein regulated inducer 
of neurite outgrowth 2 (GPRIN2), which is associated with brain development and neurite outgrowth49. Previous 
reports identified this duplication in Asian, European, and Yoruba populations (three-six copies), while no duplica-
tions were reported in the chimpanzee, orangutan, or gorilla22. We also identified 444 CNVs conserved in 1000GP 
(Supplementary Table S10), which are probably shared East Asian CNVs and are not specific to Koreans. Five 
deletions and nine duplications were found to be enriched in the Korean population using the following criteria; i) 
odds ratio >10 comparing with CNV ratio in any continents, ii) p-values < 0.01, and iii) more than five individuals 
in KoVariome. Phenotypic features were examined by searching genes against the OMIM database, resulting in 
the identification of three deletions and three duplications containing genes associated with known phenotypes 
(Fig. 5B). A high copy number deletion of UDP glucuronosyltransferase family 2 member B17 (UGT2B17), which is 
associated with bone mineral density and osteoporosis50, was observed by comparing our Korean individuals with 
EUR, AFR, and AMR populations. This finding is consistent with previous studies which reported that 66.7% of 
Korean males have a deletion of this gene, compared to only 9.3% of Swedish males51. We also observed frequent 
deletions of acyl-CoA thioesterase 1 (ACOT1), which functions to maintain the cellular levels of acyl-CoA and free 
fatty acids52. We identified the duplication of hydroxycarboxylic acid receptor 2 (HCAR2) in 12% of the Koreans, 
which is associated with lipid-lowering effects53. We excluded the gene duplications of NBPF15 and HERC2 because 
they were located at the CNV break points. These CNVs will be useful for detecting Korean-specific genetic associ-
ations with specific phenotypes in future studies, which is especially important since CNVs are analyzed less often 
than SNVs even though they likely contain important disease-relevant variations.
Conclusions
To discover disease-causing genetic variants, researchers rely on comprehensive, population-specific databases con-
taining the benign genetic variation present within specific ethnic groups. The KoVariome database was created to fill 
this need for the Korean population, and includes 5.5 TB of WGS data from 50 healthy, unrelated Korean individuals 
Figure 5. Properties of copy number variations in KoVariome. (A) The number CNVs in the Korean 
population and the portion of the repeats in a specific length range. The conserved CNVs were defined by 
searching the Database of Genomic Variants (DGV) with 70% reciprocal overlaps. See the abbreviations of 
repeats in Fig. 4B. Korean enriched CNVs were identified by searching the CNVs reported in the 1000GP. 
No. represents the number of CNVs predicted in KoVariome. The heatmap represents the odds ratio of the 
CNVs compared to the CNV ratio in a specific 1000GP continental group. Associated genes were identified 
by searching the OMIM database. Abbreviations of continent group: European (EUR), African (AFR), Native 
American (AMR), South Asian (SAS), and East Asian (EAS).
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with corresponding health metadata. Using this database, we characterized all four variation types and identified 12.7M 
SNVs, 1.7M indels, 4K SVs, and 3.6K CNVs, many of which were novel or selectively enriched in the Korean popu-
lation. Despite their close geographic proximity, the Korean population was shown to be genetically distinct from the 
Chinese and Japanese populations, highlighting the need for a Korean-specific variome to accurately identify rare dis-
ease variants in this population. Accordingly, a comprehensive comparative analysis of the population-specific variants 
within KoVariome was used to predict candidate loci, inheritance patterns, and genetic risk for several diseases, includ-
ing cancer, fibrodysplasia ossificans progressive, Van der Woude syndrome, type II diabetes mellitus, and spherocytosis. 
As genetic tests become increasingly routine components of precision healthcare, KoVariome will be an invaluable 
resource for biomedical researchers and health practitioners; and will directly benefit patients by ensuring they are 
presented with the most accurate genetic predictions of disease risks.
Methods
Sample collection and data distribution. Since 2010, the Korean variome data center (KOVAC) 
recruited volunteers for the Korea Personal Genome Project (KPGP: http://kpgp.kr). All methods used in 
this study were carried out in accordance with relevant guidelines and regulations and were approved by the 
Institutional Review Board (IRB) of the Genome Research Foundation (GRF). Informed consent for study par-
ticipation was acquired from all participants in accordance with the Korean Life Ethics bill, and all experimental 
protocols were approved by the GRF IRB. In addition to providing a blood sample for WGS, each individual 
responded to a questionnaire regarding body characteristics, habits, response to 16 allergies, family histories, 
and physical condition related to 19 disease classes (Table S1). Genomic DNA was extracted using a QIAamp 
DNA Blood Mini Kit (Qiagen, CA, USA) and 69 WGS libraries were constructed using TruSeq DNA sample 
preparation kits (Illumina, CA, USA). Sequencing was performed using Illumina HiSeq sequencers following 
the manufacturer’s instruction. The homepage of KoVariome is http://variome.net. WGS data from 50 healthy 
unrelated Korean individuals were analyzed to create the KoVariome database, which was released through the 
national FTP portal server of the KOBIC (ftp://ftp.kobic.re.kr/pub/KPGP/) and distributed through GRF (http://
pgi.re.kr), and Variome.net. All data analyzed in this study were deposited in NCBI SRA (PRJNA284338) and 
accessions for each sample were listed in Supplementary Table S2.
Analysis of SNVs and indels. The WGS data were processed according to a protocol that was evaluated by 
the technical committee of the Korean Research Institute of Standards and Science (KRISS). Genomic resources 
were downloaded from UCSC Genome bioinformatics (http://hgdownload.cse.ucsc.edu/goldenPath/hg19/big-
Zips/), including the reference human genome (GRCH37/hg19), reference genes, and repeat annotations. Raw 
DNA reads were cleaned by Sickle (https://github.com/najoshi/sickle) with a quality score >20 and read length 
>50 bp. Cleaned paired-end reads were mapped to the human reference genome using BWA54 and indels were 
realigned and recalibrated after removing the PCR duplicates. Finally, we identified SNVs and indels for each 
individual using the GATK UnifiedGenotyper (ver. GATK-Lite-2.3–9)55. To improve the quality of identified 
SNVs, we applied SNV meeting criteria of: i) read depth (DP) is 20× or higher, ii) mapping rate is 90% or higher. 
Low-quality indels were removed from future analyses using the following criteria: i) quality score <27 and DP 
<6, ii) heterozygous indels with mapped allelic valance less than 0.3.
Protein modeling of the variants. To infer the functional effects of variations, we implemented 
SnpEff-3.356. The deleterious effects of the non-synonymous SNVs were obtained by searching dbNSFP (ver. 
2.9.1), a portal database providing deleterious non-synonymous SNVs57. We then predicted the effects of each 
variant on protein function using SIFT, Polyphen2, PROVEAN, MetaSVM, and MetaLE, and further annotated 
variants using the Interpro_domain and COSMIC (Catalogue of Somatic Mutations in Cancer, ver. 71) databases. 
Previously reported SNVs and indels were identified using the dbSNP database (ver. 146). All variants shorter 
than 50 bp were then stored in this database58. The databases ClinVar (ver. 20161101)42 and OMIM (generated 
2016-11-22)59 were searched to identify known pathogenic variants.
Genetic distance calculation. The genetic distance (pi) between two samples was calculated using the 
following formula:
=pi D/N,
Chr. Start End
CNV 
Types
Average copy 
number Genesa
chr2 132,964,050 133,121,849 Dup. 4.02 MIR663B, FAM201B, ZNF806, ANKRD30BL
chr10 46,222,900 46,946,499 Del. 1.0 PTPN20, FAM35BP, AGAP4, FRMPD2B, FAM21C, BMS1P5
chr10 46,946,200 47,150,299 Dup. 4.22 NPY4R, GPRIN2, CH17-360D5.1, LINC00842, LOC102724593, HNRNPA1P33, SYT15
chr10 47,147,400 47,384,499 Del. 1.0 ANXA8, FAM35DP, LINC00842, FAM25C, AGAP9, FAM25G, BMS1P6
chr15 21,885,000 21,944,149 Dup. 6.4 LOC646214
Table 5. Copy number variations conserved in 50 Korean individuals. aGenes in the identified CNV region. 
Chr. Chromosome; Dup. duplication; Del. deletions.
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where D is the nucleotide difference between two samples and N is the number of compared positions. The sum of 
the nucleotide difference was calculated between two samples for each genomic position, which ranged from 0–1. 
A homozygous genotype composed of a reference allele was adopted as the genotype for uncalled sites.
Multidimensional Scaling (MDS) analysis. Genotype data for 84 Chinese and 86 Japanese individuals 
were obtained from Phase 3 of the HapMap project3. A total of 1,387,956 SNV loci were merged with KoVariome. 
The PLINK program was used to remove the genomic loci with MAF < 0.05, call rates < 0.05, and SNPs in link-
age disequilibrium blocks60. In total, 117,521 SNPs remained after filtering and were used in the MDS analysis. 
Five dimensional components were calculated in R with the distance matrix method “canberra” and MDS plots 
were generated using the MASS package61.
Accuracy of the SNVs. To measure the accuracy of SNV predictions, 35 individuals were genotyped with 
the AxiomTM Genome-Wide East Asian (ASI) 1 Array (Affymetrix, Inc.). The accuracy and recalls were analyzed 
using a contingency table constructed with the presence and absence of the alternative alleles analyzed from our 
pipeline and the genotyping results from the AxiomTM Genome-ASI 1 Array. The precision of calls was calculated 
by analyzing the concordance and denoted as true positive predictions (TP) from all predicted SNVs. The recalls 
were defined as TPs divided by the number of genotypes represented on the AxiomTM Genome-ASI 1 Array. The 
genotype accuracies were measured by analyzing the concordance of the genotypes between the GATK prediction 
and the results from the AxiomTM Genome-ASI 1 Array. The accuracy of the indel predictions were calculated by 
comparing genotypes between GATK predictions and the AxiomTM Genome-ASI 1 Array.
Structural variants. We applied two programs, BD62 and pindel63, to predict genome-wide SVs based on 
the discordant mate-pair and split-read information, respectively. From the bam files for each individual, inser-
tions and deletions of a length between 100 and 1 Kb were predicted by pindel (ver. 0.2.4t) and those longer than 
1Kb were predicted by BD (ver. 1.4.5)64. We next constructed unassembled genomic blocks (‘N’) from the hg19 
reference genome and examined the SVs that overlapped with these unassembled genomic regions. From this 
analysis, we discovered a high portion of spurious SVs in these regions (Supplementary Fig. S5), with the majority 
of them >100M in size. The following criteria were used to filter out spurious SVs; i) reciprocally >10% overlaps 
between SVs and un-assembled genomic blocks, ii) ‘N’s more than 50% coverage of SVs, and iii) more than 2 
un-assembled genomic blocks in the predicted SVs. After filtering, we clustered SVs that reciprocally overlapped 
>70% in any individual. Unified SVs were defined by the average start and end positions in each SV cluster. The 
novelty of each SV was defined by comparing unified SVs with those in the DGV65, with 70% reciprocal overlaps.
Copy number variations. CNVs were predicted with FREEC (ver. 10.6) using window size = 100, step 
size = 50, and breakpoint = 0.648. The spurious CNVs were enriched in >1M in length (Figure S7), which were 
filtered using the same criteria described in the SV methods above. Unified CNVs were constructed by merging 
individual’s CNVs that reciprocally overlapped by >=70%. The start and end positions of the unified CNVs were 
defined as average position of the original calls. Known CNVs were defined by comparing with CNVs in the DGV 
database65.
Data resource access. http://variome.net, http://kpgp.kr, http://koreangenome.org.
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